thiazoles has been researched along with Allergic Encephalomyelitis in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (35.71) | 29.6817 |
2010's | 15 (53.57) | 24.3611 |
2020's | 2 (7.14) | 2.80 |
Authors | Studies |
---|---|
Jhaveri, A; Kenison, JE; Khadse, N; Li, Z; Nowakowska, D; Plasencia, A; Quintana, FJ; Sherr, DH; Stanton, VP; Tezza, S; Tjon, E | 1 |
Gao, M; Guo, L; Hou, H; Miao, J; Song, X; Sun, Y | 1 |
Bello, AM; Chakka, SK; Kotra, LP; Moscarello, MA; Wasilewski, E; Wei, L | 1 |
Adams, CM; Kurnellas, MP; Rothbard, JB; Sobel, RA; Steinman, L | 1 |
Fujimura, H; Honorat, JA; Kinoshita, M; Koda, T; Mochizuki, H; Nakatsuji, Y; Okuno, T; Sakoda, S; Shirakura, T; Tada, S; Takata, K | 1 |
Buchpiguel, CA; Copray, S; de Vries, EF; Dierckx, RA; Faria, Dde P; Sijbesma, JW; Willemsen, AT | 1 |
Albrecht, S; Alexandropoulos, K; Casaccia, P; Chook, YM; de la Hera, B; Fung, HY; Haines, JD; Herbin, O; Kidd, GJ; Kuhlmann, T; McCauley, D; Moy, GA; Shacham, S; Sun, Q; Vidaurre, OG | 1 |
Abdollahi, M; Ganjali, Z; Javan, MR; Khalseh, R; Khani, M; Ramroodi, N; Ravan, H; Sanadgol, E; Sanadgol, N | 1 |
Kulkarni, P; Medishetti, R; Saxena, U; Sriram, D; Yellanki, S; Yogeeswari, P | 1 |
Furusako, S; Hayashi, M; Higashi, C; Kawaji, A; Nakamura, M; Nakao, K; Saito, R; Suzuki, T; Tsuda, N; Uruno, A; Yagishita, Y; Yamamoto, M | 1 |
Braissant, O; Defaux, A; Honegger, P; Monnet-Tschudi, F; Zurich, MG | 1 |
Boullerne, AI; Feinstein, DL; Peters, JM; Polak, PE; Richardson, JC; Vittoria Simonini, M | 1 |
Adams, SM; Bright, JJ; Chearwae, W; Iams, W; Kanakasabai, S; Walline, CC | 1 |
Axtell, R; Bhat, R; Chawla, A; Dugas, JC; Dunn, SE; Johnson, A; Moshkova, M; Mukundan, L; Nguyen, K; Sobel, RA; Steinman, L; Straus, DS | 1 |
Burns, EJ; Farez, MF; Mitsdoerffer, M; Murugaiyan, G; Quintana, FJ; Tukpah, AM; Weiner, HL | 1 |
Fortak-Michalska, M; Jurewicz, A; Matysiak, M; Orlowski, W; Selmaj, K | 1 |
Ansorge, S; Bank, U; Biton, A; Brocke, S; Reinhold, D; Täger, M | 1 |
Bandukwala, HS; Gagnon, J; Greenbaum, JA; Lamperti, ED; Lee, K; Molesworth, AM; Parr, NJ; Peters, B; Prinjha, RK; Rao, A; Smithers, N; Togher, S; Tough, DF; Witherington, J | 1 |
Brosnan, CF; Dumitrescu-Ozimek, L; Feinstein, DL; Galea, E; Gavrilyuk, V; Heneka, MT; Landreth, GE; Pershadsingh, HA; Weinberg, G; Whitacre, CC | 1 |
Assaf, B; Camelo, S; Dangond, F; De Girolami, U; Due, B; Duran, G; Ferrante, RJ; Gray, SG; Hwang, D; Iglesias, AH; Imitola, J; Khoury, SJ; Langley, B; Ratan, RR; Ryu, H; Smith, K; Stephanopoulos, G | 1 |
Dello Russo, C; Feinstein, DL; Gavrilyuk, V; Kalinin, S; Peters, JM; Polak, PE; Richardson, J; Sharp, A; Weinberg, G; Willson, TM | 1 |
Ansorge, S; Bank, U; Biton, A; Brocke, S; Faust, J; Lendeckel, U; Neubert, K; Pieper, S; Reinhold, D; Täger, M | 1 |
Kubo, K; Murooka, H; Ohno, H; Ohzeki, Y; Serizawa, I; Takanashi, H; Uemura, Y | 1 |
Ansorge, S; Born, I; Brocke, S; Faust, J; Gado, A; Izikson, L; Martin, R; Neubert, K; Quigley, L; Reinhold, D; Steinbrecher, A; Tresser, N | 1 |
Ballerini, C; Chiarugi, A; Cozzi, A; Massacesi, L; Moroni, F | 1 |
Ato, M; Iwabuchi, K; Kikuchi, S; Morohashi, T; Niino, M; Ogata, A; Onoé, K; Tashiro, K | 1 |
Bright, JJ; Natarajan, C | 1 |
Campbell, GK; DiMartino, MJ; Hanna, N; Wolff, CE | 1 |
28 other study(ies) available for thiazoles and Allergic Encephalomyelitis
Article | Year |
---|---|
Tolerogenic nanoparticles suppress central nervous system inflammation.
Topics: Animals; Bystander Effect; Drug Combinations; Encephalomyelitis, Autoimmune, Experimental; Epitopes, T-Lymphocyte; Female; Humans; Immune Tolerance; Immunosuppressive Agents; Indoles; Liposomes; Mice; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Nanoparticles; Peptide Fragments; Receptors, Aryl Hydrocarbon; Signal Transduction; T-Lymphocytes, Regulatory; Thiazoles | 2020 |
Ponesimod modulates the Th1/Th17/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Female; Inflammation Mediators; Mice; Mice, Inbred C57BL; Sphingosine 1 Phosphate Receptor Modulators; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Thiazoles | 2021 |
Novel inhibitors of protein arginine deiminase with potential activity in multiple sclerosis animal model.
Topics: Animals; Brain; Catalytic Domain; CD3 Complex; Computer Simulation; Encephalomyelitis, Autoimmune, Experimental; Hydrolases; Imidazoles; Indoles; Mice; Models, Molecular; Multiple Sclerosis; Pilot Projects; Piperazines; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Pyridines; Pyrimidines; Small Molecule Libraries; Stereoisomerism; T-Lymphocytes; Thiazoles | 2013 |
Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.
Topics: Amino Acid Sequence; Amyloid; Animals; Benzothiazoles; Biotinylation; Blood Proteins; Chemical Precipitation; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Hydrogen-Ion Concentration; Inflammation; Interleukin-6; Mice; Mice, Inbred C57BL; Molecular Chaperones; Molecular Sequence Data; Nervous System; Paralysis; Peptides; Protein Multimerization; Thiazoles | 2013 |
Xanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosis.
Topics: Animals; Axons; Central Nervous System; Encephalomyelitis, Autoimmune, Experimental; Febuxostat; Female; Mice; Multiple Sclerosis; Myelin Sheath; Reactive Oxygen Species; Thiazoles; Xanthine Oxidase | 2013 |
PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB.
Topics: Aniline Compounds; Animals; Benzothiazoles; Encephalomyelitis, Autoimmune, Experimental; Male; Multiple Sclerosis; Myelin Sheath; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Stilbenes; Thiazoles | 2014 |
Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination.
Topics: Acrylamides; Active Transport, Cell Nucleus; Animals; Axons; Cell Nucleus; Cells, Cultured; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Exportin 1 Protein; Female; Karyopherins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Proteomics; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Thiazoles; Treatment Outcome | 2015 |
Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
Topics: Animals; Blood-Brain Barrier; CD11b Antigen; Cell Movement; Cerebral Cortex; Cytokines; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation; Inflammation Mediators; Integrin alpha4beta1; Leukocyte Common Antigens; Leukocytes; Male; Mice; Monocytes; Multiple Sclerosis; Nitro Compounds; Oligopeptides; Permeability; RNA, Messenger; Thiazoles | 2015 |
Novel Zebrafish EAE model: A quick in vivo screen for multiple sclerosis.
Topics: Animals; Dexamethasone; Dimethyl Fumarate; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Immunologic Factors; Phenotype; Sulfonamides; Thiazoles; Video Recording; Zebrafish | 2017 |
The novel Nrf2 inducer TFM-735 ameliorates experimental autoimmune encephalomyelitis in mice.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; HEK293 Cells; Humans; Interleukin-17; Interleukin-6; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Pyrazoles; Thiazoles | 2017 |
Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination.
Topics: Animals; Anti-Inflammatory Agents; Antibodies; Astrocytes; Brain; Cells, Cultured; Demyelinating Diseases; Encephalitis; Encephalomyelitis, Autoimmune, Experimental; Glial Fibrillary Acidic Protein; Interferon-gamma; Interleukin-6; Lipopolysaccharides; Microglia; Myelin Basic Protein; Neurofilament Proteins; Nitric Oxide Synthase Type II; PPAR gamma; PPAR-beta; Rats; Thiazoles; Tumor Necrosis Factor-alpha | 2009 |
Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteins.
Topics: Animals; Bone Morphogenetic Proteins; Carrier Proteins; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligodendroglia; Pioglitazone; PPAR delta; Stem Cells; Thiazoles; Thiazolidinediones | 2010 |
Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis.
Topics: Animals; Cell Polarity; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Female; Interleukin-17; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenoxyacetates; PPAR delta; T-Lymphocytes, Helper-Inducer; Th1 Cells; Thiazoles | 2010 |
Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity.
Topics: Animals; Brain; CD4-Positive T-Lymphocytes; Cell Proliferation; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression; Glycoproteins; Homeodomain Proteins; Humans; Interferon-gamma; Interleukin-12; Interleukin-17; Leukocytes, Mononuclear; Lipopolysaccharides; Lymphocyte Activation; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Myeloid Cells; Nuclear Receptor Subfamily 1, Group F, Member 3; Peptide Fragments; PPAR delta; Spinal Cord; T-Box Domain Proteins; T-Lymphocytes, Helper-Inducer; Th1 Cells; Thiazoles; Tumor Necrosis Factor-alpha | 2010 |
An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis.
Topics: Adoptive Transfer; Animals; Cell Compartmentation; Cell Differentiation; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Forkhead Transcription Factors; Immune Tolerance; Indoles; Ligands; Mice; Mice, Inbred C57BL; Receptors, Aryl Hydrocarbon; T-Lymphocytes, Regulatory; Thiazoles; Tretinoin | 2010 |
Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2.
Topics: Animals; Bone Marrow Transplantation; Cell Differentiation; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Immunomodulation; Indoleamine-Pyrrole 2,3,-Dioxygenase; Meloxicam; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Thiazines; Thiazoles | 2011 |
Divergent actions by inhibitors of DP IV and APN family enzymes on CD4+ Teff cell motility and functions.
Topics: Animals; CD13 Antigens; CD4-Positive T-Lymphocytes; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Dipeptidyl Peptidase 4; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Humans; Hydroxamic Acids; Lymphocyte Activation; Lysine; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Pyrroles; Pyrrolidines; Thiazoles; Transgenes | 2011 |
Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.
Topics: Adoptive Transfer; Animals; Benzodiazepines; CD4-Positive T-Lymphocytes; Cell Differentiation; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation; Histones; Mice; Mice, Inbred C57BL; Microarray Analysis; Nuclear Proteins; Phosphorylation; Positive Transcriptional Elongation Factor B; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Salivary alpha-Amylases; Thiazoles; Transcription Factors; Transcription, Genetic | 2012 |
Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
Topics: Animals; Cerebellum; Cerebral Cortex; DNA-Binding Proteins; Encephalomyelitis, Autoimmune, Experimental; Female; Glycoproteins; Humans; Hypoglycemic Agents; I-kappa B Proteins; Ligands; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxazoles; Peptide Fragments; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Remission Induction; Spinal Cord; T-Lymphocytes; Thiazoles; Thiazolidinediones; Transcription Factors; Tyrosine | 2002 |
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.
Topics: Animals; Cell Death; Cells, Cultured; Cerebral Cortex; Cytokines; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Embryo, Mammalian; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Profiling; Gene Expression Regulation; Glycoproteins; Hydroxamic Acids; Immunohistochemistry; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Neurons; Oligonucleotide Array Sequence Analysis; Peptide Fragments; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Severity of Illness Index; Spleen; Tetrazolium Salts; Thiazoles; Time Factors | 2005 |
Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis.
Topics: Animals; Brain; Concanavalin A; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Enzymologic; Glycoproteins; Immunohistochemistry; Interferon-gamma; Lymphocyte Activation; Lymphocytes; Mice; Mice, Inbred C57BL; Myelin Basic Protein; Myelin-Oligodendrocyte Glycoprotein; Neuroglia; Peptide Fragments; PPAR delta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Severity of Illness Index; Thiazoles; Time Factors | 2005 |
Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
Topics: Animals; Antibodies; CD13 Antigens; Cell Proliferation; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Hydroxamic Acids; Immunosuppressive Agents; Leukocytes, Mononuclear; Lymphocyte Activation; Lysine; Mice; Mice, Inbred Strains; Myelin Proteolipid Protein; Peptide Fragments; Phytohemagglutinins; Pokeweed Mitogens; Protease Inhibitors; Pyrrolidines; T-Lymphocytes; Thiazoles; Transforming Growth Factor beta1; Vaccination | 2006 |
The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis.
Topics: Animals; Antigens, CD; Cell Proliferation; Cytokines; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Flow Cytometry; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Phenylurea Compounds; Protein Kinase Inhibitors; Spinal Cord; T-Lymphocytes; Thiazoles; Time Factors | 2008 |
Dipeptidyl peptidase IV in inflammatory CNS disease.
Topics: Animals; Animals, Outbred Strains; Autoimmune Diseases; Dipeptidyl Peptidase 4; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Lymphocyte Activation; Lysine; Mice; Multiple Sclerosis; Myelin Basic Protein; Pyrrolidines; Rats; Serine Proteinase Inhibitors; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer; Thiazoles | 2000 |
Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis.
Topics: Animals; Astrocytes; Brain; Cytoplasmic Granules; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Immunohistochemistry; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Mixed Function Oxygenases; Multiple Sclerosis; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Spinal Cord; Sulfonamides; Thiazoles | 2001 |
Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma.
Topics: Animals; Cell Division; Chromans; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Female; Inflammation Mediators; Mice; Mice, Inbred C57BL; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Receptors, Cytoplasmic and Nuclear; Reference Values; RNA, Messenger; T-Lymphocytes; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2001 |
Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation.
Topics: Animals; Cell Differentiation; Cells, Cultured; DNA-Binding Proteins; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Immunologic Factors; Interleukin-12; Janus Kinase 2; Kinetics; Lymphocyte Activation; Macrophages; Mice; Microglia; Myelin Basic Protein; Prostaglandin D2; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Spinal Cord; Th1 Cells; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |
Inhibition of experimental allergic encephalomyelitis by a new anti-inflammatory compound--SK&F 86002.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Encephalomyelitis, Autoimmune, Experimental; Imidazoles; Rats; Rats, Inbred Lew; Thiazoles | 1988 |